Cetrorelix
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Premenopause
Conditions
Premenopause
Trial Timeline
Apr 1, 2006 → Feb 1, 2007
NCT ID
NCT00628121About Cetrorelix
Cetrorelix is a pre-clinical stage product being developed by Shionogi for Premenopause. The current trial status is completed. This product is registered under clinical trial identifier NCT00628121. Target conditions include Premenopause.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00628121 | Pre-clinical | Completed |